Christos Moustakis
Canterbury Christ Church University, University Hospital Münster
Papers
3
Total Citations
100
H-Index
3
About
Dr. Christos Moustakis is a leading medical physicist whose research centers on advancing stereotactic body radiotherapy (SBRT) for lung and spinal cancers. His work is pivotal in establishing robust, reproducible treatment planning protocols that bridge the gap between different institutions and technologies. Dr. Moustakis’s most influential contribution is his landmark 2017 planning benchmark study for SBRT of early-stage non-small cell lung cancer (NSCLC), which has garnered 54 citations and serves as a critical reference for standardizing pulmonary SBRT. He further refined this field with his 2021 study proposing dose prescription to the mean internal target volume dose, a method designed to improve interinstitutional and intertechnology consistency by addressing the large variations in dose profiles and normalization. Complementing this, his 2018 work on treatment planning for spinal radiosurgery (35 citations) demonstrates his versatility in tackling complex anatomical sites. Through these studies, Dr. Moustakis has provided the radiation oncology community with essential tools for harmonizing SBRT delivery, directly enhancing the safety, comparability, and quality of treatments for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1Planning benchmark study for SBRT of early stage NSCLC54 citations · 2017
- 2Treatment planning for spinal radiosurgery35 citations · 2018
- 3